InsidersTradesSigma
Total declarations
Company
▲ Purchases (11 ops.)
▼ Sales (1 ops.)
Insider track record
Board DirectorDisclosed buys
11
Disclosed sells
1
T+90 hit rate
0%
T+90 mean return
-28.1%
Across 7 buy signals with a settled T+90 return. Return basis: close on the day after publication.
Signal history
Browse the complete record of transactions filed by Encrantz Staffan, Director. Insider active across 1 company, notably Sight Sciences, Inc.. Aggregated, 19 reports have been recorded. Breakdown: 11 buys · 1 sell. Total volume traded: €26.8m. History available since 19 July 2021. The latest transaction was disclosed on 4 June 2026 (Attribution). Regulator: SEC (Form 4). All data is free.
Declarations19 total
14,100 sharesCommon StockSEC:0001193125-26-267752:0
Ideal exit: 7 Mar 2027 (T+270)
28,261 shares0Common StockSEC:0001193125-26-259570:0
120,000 shares@ US$2.531.0% of flowCommon StockSEC:0000950170-25-039010:0
551,802 shares@ US$3.737.2% of flowCommon StockSEC:0000950170-24-129885:0
17,366 shares0Common StockSEC:0000950170-24-071516:0
3,223 shares@ US$3.500.0% of flowCommon StockSEC:0000950170-23-067435:0
Ideal exit: 25 Aug 2024 (T+270)
21,855 shares@ US$3.08520.2% of flowCommon StockSEC:0000950170-23-066532:0
Ideal exit: 20 Aug 2024 (T+270)
79,234 shares@ US$2.24890.6% of flowCommon StockSEC:0000950170-23-065919:0
Ideal exit: 16 Aug 2024 (T+270)
339 shares@ US$2.000.0% of flowCommon StockSEC:0000950170-23-065273:0
Ideal exit: 12 Aug 2024 (T+270)
3,462 shares@ US$1.9970.0% of flowCommon StockSEC:0000950170-23-064582:0
Ideal exit: 10 Aug 2024 (T+270)
11,940 shares0Common StockSEC:0000950170-23-064579:0
11,940 shares0Common StockSEC:0000899243-23-015385:0
1,802 shares@ US$7.98110.0051% mcap0.1% of flowCommon StockSEC:0000899243-22-018500:0
Ideal exit: 7 Feb 2023 (T+270)
84,254 shares@ US$18.845.2% of flowCommon StockSEC:0000899243-21-046456
Ideal exit: 26 Aug 2022 (T+270)
84,254 shares@ US$18.840.52% mcap5.7% of flowCommon StockSEC:0000899243-21-046456:0
Ideal exit: 26 Aug 2022 (T+270)
527,048 shares@ US$24.004.02% mcap44.3% of flowCommon StockSEC:0000899243-21-040878:0
Ideal exit: 15 Jul 2022 (T+270)
527,048 shares@ US$24.0040.2% of flowCommon StockSEC:0000899243-21-040878
Ideal exit: 15 Jul 2022 (T+270)
2,970,070 shares0Common StockSEC:0000899243-21-028879
2,970,070 shares0Common StockSEC:0000899243-21-028879:0
19 of 19 declarations
About Encrantz Staffan
Staffan Encrantz is a Director at Sight Sciences, Inc. As a board member, he participates in overseeing the company's activities and making strategic decisions. Encrantz brings valuable insight through his experience in the healthcare sector, thereby contributing to the governance and direction of the company.
